{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Bétalaïnes : Questions médicales les plus fréquentes",
"headline": "Bétalaïnes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Bétalaïnes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-21",
"dateModified": "2025-02-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Bétalaïnes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tyrosine",
"url": "https://questionsmedicales.fr/mesh/D014443",
"about": {
"@type": "MedicalCondition",
"name": "Tyrosine",
"code": {
"@type": "MedicalCode",
"code": "D014443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.125.072.050.875"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bétacyanines",
"alternateName": "Betacyanins",
"url": "https://questionsmedicales.fr/mesh/D050859",
"about": {
"@type": "MedicalCondition",
"name": "Bétacyanines",
"code": {
"@type": "MedicalCode",
"code": "D050859",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.125.072.050.875.064.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Bétalaïnes",
"alternateName": "Betalains",
"code": {
"@type": "MedicalCode",
"code": "D050858",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Francisco García-Carmona",
"url": "https://questionsmedicales.fr/author/Francisco%20Garc%C3%ADa-Carmona",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular A, Unidad Docente de Biología, Facultad de Veterinaria, Regional Campus of International Excellence \"Campus Mare Nostrum″, Universidad de Murcia, 30100 Murcia, Spain."
}
},
{
"@type": "Person",
"name": "Fernando Gandía-Herrero",
"url": "https://questionsmedicales.fr/author/Fernando%20Gand%C3%ADa-Herrero",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular A, Unidad Docente de Biología, Facultad de Veterinaria, Regional Campus of International Excellence \"Campus Mare Nostrum″, Universidad de Murcia, 30100 Murcia, Spain."
}
},
{
"@type": "Person",
"name": "Paula Henarejos-Escudero",
"url": "https://questionsmedicales.fr/author/Paula%20Henarejos-Escudero",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular A, Unidad Docente de Biología, Facultad de Veterinaria, Regional Campus of International Excellence \"Campus Mare Nostrum″, Universidad de Murcia, 30100 Murcia, Spain."
}
},
{
"@type": "Person",
"name": "M Alejandra Guerrero-Rubio",
"url": "https://questionsmedicales.fr/author/M%20Alejandra%20Guerrero-Rubio",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular A, Unidad Docente de Biología, Facultad de Veterinaria, Regional Campus of International Excellence \"Campus Mare Nostrum″, Universidad de Murcia, 30100 Murcia, Spain."
}
},
{
"@type": "Person",
"name": "Alfonso Timoneda",
"url": "https://questionsmedicales.fr/author/Alfonso%20Timoneda",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Sciences, University of Cambridge, Tennis Court Road, Cambridge, CB2 3EA, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Successful treatment of cortical visual impairment in children using anti-amblyopia treatment despite the absence of amblyopia: a case report.",
"datePublished": "2024-07-02",
"url": "https://questionsmedicales.fr/article/38956699",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13052-024-01679-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "National survey of amblyopia treatment in Japan: comparison with amblyopia treatment study results of the pediatric eye disease investigator group.",
"datePublished": "2022-12-12",
"url": "https://questionsmedicales.fr/article/36508061",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10384-022-00968-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of fixation characteristics in amblyopia using microperimetry.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37184805",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-023-02748-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "SPEctacle Correction for the TReatment of Amblyopia (SPECTRA): study protocol for a prospective non-randomised interventional trial in adults with anisometropic/mixed mechanism amblyopia.",
"datePublished": "2024-07-01",
"url": "https://questionsmedicales.fr/article/38950991",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2023-080151"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analyses of eye movement parameters in children with anisometropic amblyopia.",
"datePublished": "2024-07-09",
"url": "https://questionsmedicales.fr/article/38982388",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12886-024-03539-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides aminés",
"item": "https://questionsmedicales.fr/mesh/D000596"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides aminés cycliques",
"item": "https://questionsmedicales.fr/mesh/D000598"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides aminés aromatiques",
"item": "https://questionsmedicales.fr/mesh/D024322"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tyrosine",
"item": "https://questionsmedicales.fr/mesh/D014443"
},
{
"@type": "ListItem",
"position": 7,
"name": "Bétalaïnes",
"item": "https://questionsmedicales.fr/mesh/D050858"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Bétalaïnes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Bétalaïnes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Bétalaïnes",
"description": "Comment identifier la présence de bétalaïnes ?\nQuels tests sont utilisés pour détecter les bétalaïnes ?\nLes bétalaïnes sont-elles visibles à l'œil nu ?\nPeut-on mesurer les bétalaïnes dans le sang ?\nY a-t-il des méthodes standardisées pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D050858?mesh_terms=Amblyopia&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Bétalaïnes",
"description": "Quels sont les effets des bétalaïnes sur la santé ?\nLes bétalaïnes provoquent-elles des allergies ?\nLes bétalaïnes affectent-elles la digestion ?\nY a-t-il des effets secondaires connus ?\nLes bétalaïnes peuvent-elles colorer les urines ?",
"url": "https://questionsmedicales.fr/mesh/D050858?mesh_terms=Amblyopia&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Bétalaïnes",
"description": "Comment intégrer les bétalaïnes dans l'alimentation ?\nLes bétalaïnes aident-elles à prévenir des maladies ?\nY a-t-il des recommandations de consommation ?\nLes bétalaïnes sont-elles bénéfiques pour la peau ?\nPeut-on trouver des bétalaïnes dans des suppléments ?",
"url": "https://questionsmedicales.fr/mesh/D050858?mesh_terms=Amblyopia&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Bétalaïnes",
"description": "Les bétalaïnes sont-elles utilisées en médecine ?\nComment les bétalaïnes sont-elles administrées ?\nLes bétalaïnes sont-elles efficaces contre le cancer ?\nPeut-on utiliser les bétalaïnes pour traiter l'inflammation ?\nY a-t-il des interactions médicamenteuses avec les bétalaïnes ?",
"url": "https://questionsmedicales.fr/mesh/D050858?mesh_terms=Amblyopia&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Bétalaïnes",
"description": "Quelles complications peuvent survenir avec une surconsommation ?\nLes bétalaïnes peuvent-elles causer des problèmes rénaux ?\nY a-t-il des risques pour les personnes allergiques ?\nLes bétalaïnes peuvent-elles interférer avec des traitements médicaux ?\nLes bétalaïnes peuvent-elles affecter la pression artérielle ?",
"url": "https://questionsmedicales.fr/mesh/D050858?mesh_terms=Amblyopia&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Bétalaïnes",
"description": "Qui devrait éviter les bétalaïnes ?\nLes personnes atteintes de diabète peuvent-elles consommer des bétalaïnes ?\nLes bétalaïnes sont-elles sûres pour les femmes enceintes ?\nLes bétalaïnes présentent-elles des risques pour les enfants ?\nLes personnes atteintes de maladies rénales doivent-elles éviter les bétalaïnes ?",
"url": "https://questionsmedicales.fr/mesh/D050858?mesh_terms=Amblyopia&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier la présence de bétalaïnes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La présence de bétalaïnes peut être identifiée par des tests colorimétriques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les bétalaïnes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la chromatographie peuvent être utilisés pour isoler et identifier les bétalaïnes."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes sont-elles visibles à l'œil nu ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les bétalaïnes donnent des couleurs vives aux plantes, visibles à l'œil nu."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les bétalaïnes dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que les bétalaïnes peuvent être mesurées dans le plasma sanguin."
}
},
{
"@type": "Question",
"name": "Y a-t-il des méthodes standardisées pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des méthodes standardisées existent pour l'analyse des bétalaïnes dans les aliments."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des bétalaïnes sur la santé ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bétalaïnes ont des propriétés antioxydantes et anti-inflammatoires bénéfiques."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes provoquent-elles des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques aux bétalaïnes sont rares mais possibles chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes affectent-elles la digestion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bétalaïnes peuvent favoriser la digestion en stimulant la production de bile."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires connus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires sont rares, mais une consommation excessive peut causer des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes peuvent-elles colorer les urines ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la consommation de betteraves riches en bétalaïnes peut colorer les urines en rouge."
}
},
{
"@type": "Question",
"name": "Comment intégrer les bétalaïnes dans l'alimentation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consommez des aliments comme les betteraves, les figues de barbarie et les amaranthes."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes aident-elles à prévenir des maladies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent contribuer à la prévention des maladies cardiovasculaires grâce à leurs propriétés antioxydantes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations de consommation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de consommer des aliments riches en bétalaïnes plusieurs fois par semaine."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes sont-elles bénéfiques pour la peau ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent aider à protéger la peau des dommages causés par les radicaux libres."
}
},
{
"@type": "Question",
"name": "Peut-on trouver des bétalaïnes dans des suppléments ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des suppléments de bétalaïnes sont disponibles sur le marché pour leurs bienfaits santé."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes sont-elles utilisées en médecine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les bétalaïnes sont étudiées pour leurs propriétés anti-inflammatoires et anticancéreuses."
}
},
{
"@type": "Question",
"name": "Comment les bétalaïnes sont-elles administrées ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être consommées sous forme de jus, de compléments ou d'extraits concentrés."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes sont-elles efficaces contre le cancer ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études préliminaires montrent que les bétalaïnes peuvent inhiber la croissance tumorale."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser les bétalaïnes pour traiter l'inflammation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les bétalaïnes ont des propriétés anti-inflammatoires qui peuvent aider à réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des interactions médicamenteuses avec les bétalaïnes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études sont nécessaires, mais aucune interaction significative n'a été rapportée jusqu'à présent."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une surconsommation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surconsommation peut entraîner des troubles digestifs comme des ballonnements ou des diarrhées."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes peuvent-elles causer des problèmes rénaux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune preuve solide ne lie les bétalaïnes à des problèmes rénaux, mais la modération est conseillée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour les personnes allergiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes allergiques aux plantes peuvent avoir des réactions aux bétalaïnes, bien que rares."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes peuvent-elles interférer avec des traitements médicaux ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études sont nécessaires, mais aucune interférence significative n'a été rapportée jusqu'à présent."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes peuvent-elles affecter la pression artérielle ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les bétalaïnes peuvent aider à réguler la pression artérielle."
}
},
{
"@type": "Question",
"name": "Qui devrait éviter les bétalaïnes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies alimentaires devraient être prudentes."
}
},
{
"@type": "Question",
"name": "Les personnes atteintes de diabète peuvent-elles consommer des bétalaïnes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais avec modération, car les betteraves peuvent contenir des sucres naturels."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes sont-elles sûres pour les femmes enceintes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, les bétalaïnes sont considérées comme sûres, mais il est conseillé de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Les bétalaïnes présentent-elles des risques pour les enfants ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bétalaïnes sont généralement sûres pour les enfants, mais une consommation excessive doit être évitée."
}
},
{
"@type": "Question",
"name": "Les personnes atteintes de maladies rénales doivent-elles éviter les bétalaïnes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter un médecin, car les bétalaïnes peuvent affecter la fonction rénale."
}
}
]
}
]
}
Cortical visual impairment (CVI) is a verifiable visual dysfunction that cannot be attributed to disorders of the anterior visual pathways or any potentially co-occurring ocular impairment. Given the ...
This case report presents a 5-year-old girl with CVI secondary to hypoxic-ischemic injury, resulting in visual impairment, dyspraxia, and abnormal visual evoked potential testing. The girl did not suf...
The case report shows that addressing even minor refractive errors and implementing anti-amblyopia therapy can significantly improve vision in children with CVI, even without co-existing amblyopia. It...
To investigate the treatment policy for amblyopia in Japan as of 2017 through a survey of multiple facilities and to compare the findings with those obtained by the Amblyopia Treatment Study (ATS) of ...
Questionnaire survey study....
A questionnaire was sent to 181 facilities where patients with amblyopia are being treated. The outcomes of the present survey were compared with the results of the ATS study, and the coincidence rate...
The questionnaire response rate was 68.0%. The treatment plan that showed the highest agreement between the outcomes of the ATS study and the present study was whether or not treatment was to be given...
The amblyopia treatment in Japan survey did not always agree with the research results of the ATS. Japanese ophthalmologists tend to make treatment plans for amblyopia according to their clinical expe...
To evaluate fixation characteristics in amblyopia using macular analyzer integrity assessment (MAIA) microperimetry and to investigate the factors affecting fixation stability....
This prospective, cross-sectional study enrolled a total of 58 amblyopic patients who were between 8 and 55 years old. Average threshold macular sensitivity (AT) and fixation characteristics were asse...
AT and fixation stability indices (P1, P2, BCEA 63%, BCEA 95%) were worse in the amblyopic eyes than in the fellow eyes (p < 0.05, for all indices). There was a moderate positive correlation between b...
Our data showed a decrease in fixation stability, a positive correlation between fixation stability and BCVA, and a negative correlation between preferred fixation eccentricity and BCVA in amblyopic e...
Amblyopia is a neurodevelopmental vision disorder typically affecting one eye, resulting in compromised binocular function. While evidence-based treatments exist for children, there are no widely acce...
SPEctacle Correction for the TReatment of Amblyopia is a prospective non-randomised interventional trial. The following criteria for amblyopia will be used: best corrected visual acuity (BCVA) in the ...
Human ethics approval was obtained from the respective ethics board of the Hong Kong Polytechnic University (HSEARS20210915002) and the University of Waterloo (#44235). The study protocol will conform...
NCT05394987; clinicaltrials.org....
To investigate the characteristics of eye movement in children with anisometropic amblyopia, and to compare those characteristics with eye movement in a control group....
31 children in the anisometropic amblyopia group (31 amblyopic eyes in group A, 31 contralateral eyes in group B) and 24 children in the control group (48 eyes in group C). Group A was subdivided into...
Mean and maximum saccade latencies, as well as mean and maximum saccade amplitudes, were significantly greater in group A than in groups B and C before and after treatment (P < 0.05). Mean and maximum...
Eye movement parameters significantly differed between contralateral normal eyes and control eyes. Clinical evaluation of children with anisometropic amblyopia should not focus only on static visual a...
To compare and assess the choroidal and retinal microstructural vascularity in amblyopic eyes with the fellow eyes in anisometropic amblyopic children using angiography optical coherence tomography (A...
The blinq (Rebion Inc) is a new screening device designed to directly detect amblyopia and strabismus rather than amblyopia risk factors. We performed an independent assessment of the effectiveness of...
Prospective clinical validity analysis of a screening device based on sensitivity and specificity....
Children presenting for examination in the pediatric ophthalmology clinic underwent screening with the blinq before examination by a pediatric ophthalmologist blinded to the screening results. Results...
In our cohort of 267 children with an average age of 6.3 years, the sensitivity of the blinq to detect amblyopia or any constant strabismus was 87.5% (78.2%-93.8%) and specificity was 51.3% (43.9%-58....
Our results support use of the blinq as a screening device to detect amblyopia and strabismus in children....
Amblyopia is the decreased best-corrected visual acuity (BCVA) in one or both eyes caused by the abnormal processing of visual input during development. One common cause of amblyopia is anisometropia,...
To analyze the top 100 most cited papers related to amblyopia....
A bibliographic search in the Institute for Scientific Information Web of Knowledge across 55 years was performed....
Eighty-nine of the 100 papers were published in first-quartile journals. Half (50) of the senior authors were from the USA. Most papers dealt with clinical science (72) and included original research ...
Half of the papers were published between 2000 and 2010 and were spearheaded by PEDIG. Most papers dealt with treatment and pathophysiology. This study provides an important historical perspective, em...
Amblyopia is an important public health concern. While home-based screening may present an effective solution, this has not been rigorously assessed in a systematic review. A systematic review was per...